Add an In-House Specialty Pharmacy to an Infusion Platform

1. 1

   Understand why in-house beats white-bagging

   White-bagging (the payer's specialty pharmacy ships the drug to your center) removes your drug margin, fragments the patient experience, and can delay or cancel infusions when the drug does not arrive. An in-house specialty pharmacy lets the platform control sourcing, dispensing, and timing, capturing margin and improving referral conversion. Understand this economic and clinical case; it justifies the heavy build.

2. 2

   Get specialty-pharmacy licensing and accreditation

   A specialty pharmacy needs state pharmacy licensing, compliance with USP standards for the drugs it handles, and the accreditations payers and manufacturers require (such as URAC or ACHC specialty-pharmacy accreditation). This licensing and accreditation stack is the main barrier and the main runway. Start it early and build to the accreditor's standards.

3. 3

   Secure drug access and payer contracts

   Many specialty and limited-distribution drugs require manufacturer approval to dispense, and payers must contract with your pharmacy for it to be in-network. Securing limited-distribution-drug access and payer and PBM contracts is often the hardest commercial step. Without drug access and payer contracts, the pharmacy cannot serve your patients.

4. 4

   Integrate the pharmacy into the infusion flow

   The value comes from a seamless flow: a referral arrives, the in-house pharmacy sources and dispenses the drug, and the center administers it, all under one roof. Integrate the pharmacy's systems with the infusion platform's scheduling and referral management. The tighter the integration, the higher the referral conversion and the better the patient experience.

5. 5

   Manage the added working-capital and compliance load

   The in-house pharmacy adds drug inventory (and its buy-and-bill working-capital gap) and pharmacy compliance on top of the infusion business, so plan financing and compliance staffing accordingly. Done well, it protects the platform against biosimilar and white-bagging margin pressure. Done carelessly, it doubles the capital and compliance exposure without the payoff.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Infusion-platform operators and pharmacists building vertical integration into drug sourcing

Not for: Not for a standalone founder without an infusion platform to bundle it into; the value is the integration, not a freestanding pharmacy. Not for an operator unwilling to fund pharmacy licensing, accreditation, and drug working capital. And not for anyone who confuses this with a long-term-care or retail pharmacy, which are different businesses (existing cards).